Industry Research Reports

Home > Reports > Pharma & Healthcare > Transthyretin Stabilizer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Transthyretin Stabilizer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-10

Pages: 117 Pages

Report ld: 3014119

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Transthyretin Stabilizer Market Size(US$)

CAGR 2024-2030

6.9%

Market Size,2030

USD 2,372.8

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,590 million

Market Forecast in 2030(Value)

US$ 2,372.8 million

CAGR

6.9%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.

TTR stabilizers work by binding to and stabilizing the TTR protein, preventing it from misfolding and forming amyloid fibrils. By stabilizing the TTR protein, these medications aim to slow down or halt the progression of the disease and potentially alleviate symptoms.

The global market for Transthyretin Stabilizer was estimated to be worth US$ 1480 million in 2023 and is forecast to a readjusted size of US$ 2372.8 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

The global transthyretin stabilizer market refers to the market for medications and compounds used in the treatment of transthyretin amyloidosis (ATTR) by stabilizing the transthyretin (TTR) protein. This market encompasses various drugs that have been developed or under development as TTR stabilizers.

Currently, there are several TTR stabilizers that have gained regulatory approval or are in advanced stages of clinical development. The market is primarily driven by the rising prevalence of ATTR, increasing awareness of the disease, and the need for effective treatment options.

One of the key drugs in the market is tafamidis, which is approved in several countries for the treatment of ATTR polyneuropathy. Tafamidis has shown to stabilize TTR and slow disease progression in clinical trials. Other drugs such as diflunisal, AG10, inotersen, and patisiran are also being investigated and have shown promising results in clinical studies.

The market is expected to witness significant growth as more research is conducted on the development of TTR stabilizers and as regulatory approvals are obtained for these drugs in different regions. Additionally, the ongoing efforts to increase disease awareness among healthcare professionals and patients are likely to contribute to the market growth.

Key players in the global transthyretin stabilizer market include pharmaceutical companies such as Pfizer Inc., Alnylam Pharmaceuticals, Inc., Eidos Therapeutics, and Ionis Pharmaceuticals Inc., among others. These companies invest in research and development activities to develop new TTR stabilizers and expand their product portfolios.

Geographically, North America and Europe are leading regions in the market, primarily due to the higher prevalence of ATTR and the presence of established healthcare infrastructure. However, as awareness and diagnosis of ATTR improve in other regions such as Asia Pacific and Latin America, these regions are likely to exhibit significant growth opportunities.

In conclusion, the global transthyretin stabilizer market is expected to grow as more effective treatments are developed and approved for ATTR. The market is driven by the increasing prevalence of the disease and the need for therapies that can stabilize the TTR protein and slow disease progression.

MARKET SEGMENTATION

By Company

Pfizer Inc.
Merck & Co.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Corino Therapeutics Inc.
Alnylam Pharmaceuticals
Bellus Health Inc.
Ionis Pharmaceuticals, Inc.
Proclara Bioscience
Arturus Therapeutics
Prothena Corporation Plc.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Diflunisal
Tafamidis
Others

Segment by Application

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Transthyretin Stabilizer, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Transthyretin Stabilizer by region & country, by Type, and by Application.

The Transthyretin Stabilizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Stabilizer.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Transthyretin Stabilizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Transthyretin Stabilizer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Transthyretin Stabilizer in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Transthyretin Stabilizer Product Introduction

1.2 Global Transthyretin Stabilizer Market Size Forecast

1.2.1 Global Transthyretin Stabilizer Sales Value (2019-2030)

1.2.2 Global Transthyretin Stabilizer Sales Volume (2019-2030)

1.2.3 Global Transthyretin Stabilizer Sales Price (2019-2030)

1.3 Transthyretin Stabilizer Market Trends & Drivers

1.3.1 Transthyretin Stabilizer Industry Trends

1.3.2 Transthyretin Stabilizer Market Drivers & Opportunity

1.3.3 Transthyretin Stabilizer Market Challenges

1.3.4 Transthyretin Stabilizer Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Transthyretin Stabilizer Players Revenue Ranking (2023)

2.2 Global Transthyretin Stabilizer Revenue by Company (2019-2024)

2.3 Global Transthyretin Stabilizer Players Sales Volume Ranking (2023)

2.4 Global Transthyretin Stabilizer Sales Volume by Company Players (2019-2024)

2.5 Global Transthyretin Stabilizer Average Price by Company (2019-2024)

2.6 Key Manufacturers Transthyretin Stabilizer Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Transthyretin Stabilizer Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Transthyretin Stabilizer

2.9 Transthyretin Stabilizer Market Competitive Analysis

2.9.1 Transthyretin Stabilizer Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Transthyretin Stabilizer Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Stabilizer as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Diflunisal

3.1.2 Tafamidis

3.1.3 Others

3.2 Global Transthyretin Stabilizer Sales Value by Type

3.2.1 Global Transthyretin Stabilizer Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Transthyretin Stabilizer Sales Value, by Type (2019-2030)

3.2.3 Global Transthyretin Stabilizer Sales Value, by Type (%) (2019-2030)

3.3 Global Transthyretin Stabilizer Sales Volume by Type

3.3.1 Global Transthyretin Stabilizer Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Transthyretin Stabilizer Sales Volume, by Type (2019-2030)

3.3.3 Global Transthyretin Stabilizer Sales Volume, by Type (%) (2019-2030)

3.4 Global Transthyretin Stabilizer Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Drug Stores

4.1.4 Online Pharmacies

4.1.5 Others

4.2 Global Transthyretin Stabilizer Sales Value by Application

4.2.1 Global Transthyretin Stabilizer Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Transthyretin Stabilizer Sales Value, by Application (2019-2030)

4.2.3 Global Transthyretin Stabilizer Sales Value, by Application (%) (2019-2030)

4.3 Global Transthyretin Stabilizer Sales Volume by Application

4.3.1 Global Transthyretin Stabilizer Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Transthyretin Stabilizer Sales Volume, by Application (2019-2030)

4.3.3 Global Transthyretin Stabilizer Sales Volume, by Application (%) (2019-2030)

4.4 Global Transthyretin Stabilizer Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Transthyretin Stabilizer Sales Value by Region

5.1.1 Global Transthyretin Stabilizer Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Transthyretin Stabilizer Sales Value by Region (2019-2024)

5.1.3 Global Transthyretin Stabilizer Sales Value by Region (2025-2030)

5.1.4 Global Transthyretin Stabilizer Sales Value by Region (%), (2019-2030)

5.2 Global Transthyretin Stabilizer Sales Volume by Region

5.2.1 Global Transthyretin Stabilizer Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Transthyretin Stabilizer Sales Volume by Region (2019-2024)

5.2.3 Global Transthyretin Stabilizer Sales Volume by Region (2025-2030)

5.2.4 Global Transthyretin Stabilizer Sales Volume by Region (%), (2019-2030)

5.3 Global Transthyretin Stabilizer Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Transthyretin Stabilizer Sales Value, 2019-2030

5.4.2 North America Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Transthyretin Stabilizer Sales Value, 2019-2030

5.5.2 Europe Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Transthyretin Stabilizer Sales Value, 2019-2030

5.6.2 Asia Pacific Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Transthyretin Stabilizer Sales Value, 2019-2030

5.7.2 South America Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Transthyretin Stabilizer Sales Value, 2019-2030

5.8.2 Middle East & Africa Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Transthyretin Stabilizer Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Transthyretin Stabilizer Sales Value

6.2.1 Key Countries/Regions Transthyretin Stabilizer Sales Value, 2019-2030

6.2.2 Key Countries/Regions Transthyretin Stabilizer Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Transthyretin Stabilizer Sales Value, 2019-2030

6.3.2 United States Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Transthyretin Stabilizer Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Transthyretin Stabilizer Sales Value, 2019-2030

6.4.2 Europe Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Transthyretin Stabilizer Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Transthyretin Stabilizer Sales Value, 2019-2030

6.5.2 China Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

6.5.3 China Transthyretin Stabilizer Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Transthyretin Stabilizer Sales Value, 2019-2030

6.6.2 Japan Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Transthyretin Stabilizer Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Transthyretin Stabilizer Sales Value, 2019-2030

6.7.2 South Korea Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Transthyretin Stabilizer Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Transthyretin Stabilizer Sales Value, 2019-2030

6.8.2 Southeast Asia Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Transthyretin Stabilizer Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Transthyretin Stabilizer Sales Value, 2019-2030

6.9.2 India Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

6.9.3 India Transthyretin Stabilizer Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer Inc.

7.1.1 Pfizer Inc. Company Information

7.1.2 Pfizer Inc. Introduction and Business Overview

7.1.3 Pfizer Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Pfizer Inc. Transthyretin Stabilizer Product Offerings

7.1.5 Pfizer Inc. Recent Development

7.2 Merck & Co.

7.2.1 Merck & Co. Company Information

7.2.2 Merck & Co. Introduction and Business Overview

7.2.3 Merck & Co. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Merck & Co. Transthyretin Stabilizer Product Offerings

7.2.5 Merck & Co. Recent Development

7.3 AstraZeneca Plc.

7.3.1 AstraZeneca Plc. Company Information

7.3.2 AstraZeneca Plc. Introduction and Business Overview

7.3.3 AstraZeneca Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.3.4 AstraZeneca Plc. Transthyretin Stabilizer Product Offerings

7.3.5 AstraZeneca Plc. Recent Development

7.4 GlaxoSmithKline Plc.

7.4.1 GlaxoSmithKline Plc. Company Information

7.4.2 GlaxoSmithKline Plc. Introduction and Business Overview

7.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.4.4 GlaxoSmithKline Plc. Transthyretin Stabilizer Product Offerings

7.4.5 GlaxoSmithKline Plc. Recent Development

7.5 Corino Therapeutics Inc.

7.5.1 Corino Therapeutics Inc. Company Information

7.5.2 Corino Therapeutics Inc. Introduction and Business Overview

7.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Corino Therapeutics Inc. Transthyretin Stabilizer Product Offerings

7.5.5 Corino Therapeutics Inc. Recent Development

7.6 Alnylam Pharmaceuticals

7.6.1 Alnylam Pharmaceuticals Company Information

7.6.2 Alnylam Pharmaceuticals Introduction and Business Overview

7.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Alnylam Pharmaceuticals Transthyretin Stabilizer Product Offerings

7.6.5 Alnylam Pharmaceuticals Recent Development

7.7 Bellus Health Inc.

7.7.1 Bellus Health Inc. Company Information

7.7.2 Bellus Health Inc. Introduction and Business Overview

7.7.3 Bellus Health Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Bellus Health Inc. Transthyretin Stabilizer Product Offerings

7.7.5 Bellus Health Inc. Recent Development

7.8 Ionis Pharmaceuticals, Inc.

7.8.1 Ionis Pharmaceuticals, Inc. Company Information

7.8.2 Ionis Pharmaceuticals, Inc. Introduction and Business Overview

7.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Offerings

7.8.5 Ionis Pharmaceuticals, Inc. Recent Development

7.9 Proclara Bioscience

7.9.1 Proclara Bioscience Company Information

7.9.2 Proclara Bioscience Introduction and Business Overview

7.9.3 Proclara Bioscience Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Proclara Bioscience Transthyretin Stabilizer Product Offerings

7.9.5 Proclara Bioscience Recent Development

7.10 Arturus Therapeutics

7.10.1 Arturus Therapeutics Company Information

7.10.2 Arturus Therapeutics Introduction and Business Overview

7.10.3 Arturus Therapeutics Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Arturus Therapeutics Transthyretin Stabilizer Product Offerings

7.10.5 Arturus Therapeutics Recent Development

7.11 Prothena Corporation Plc.

7.11.1 Prothena Corporation Plc. Company Information

7.11.2 Prothena Corporation Plc. Introduction and Business Overview

7.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Prothena Corporation Plc. Transthyretin Stabilizer Product Offerings

7.11.5 Prothena Corporation Plc. Recent Development

8 Industry Chain Analysis

8.1 Transthyretin Stabilizer Industrial Chain

8.2 Transthyretin Stabilizer Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Transthyretin Stabilizer Sales Model

8.5.2 Sales Channel

8.5.3 Transthyretin Stabilizer Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Transthyretin Stabilizer Market Trends

Table 2. Transthyretin Stabilizer Market Drivers & Opportunity

Table 3. Transthyretin Stabilizer Market Challenges

Table 4. Transthyretin Stabilizer Market Restraints

Table 5. Global Transthyretin Stabilizer Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Transthyretin Stabilizer Revenue Market Share by Company (2019-2024)

Table 7. Global Transthyretin Stabilizer Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Transthyretin Stabilizer Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Transthyretin Stabilizer Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Transthyretin Stabilizer Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Transthyretin Stabilizer Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Transthyretin Stabilizer

Table 13. Global Transthyretin Stabilizer Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Stabilizer as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Transthyretin Stabilizer Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Transthyretin Stabilizer Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Transthyretin Stabilizer Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Transthyretin Stabilizer Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Transthyretin Stabilizer Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Transthyretin Stabilizer Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Transthyretin Stabilizer Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Transthyretin Stabilizer Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Transthyretin Stabilizer Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Transthyretin Stabilizer Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Transthyretin Stabilizer Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Transthyretin Stabilizer Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Transthyretin Stabilizer Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Transthyretin Stabilizer Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Transthyretin Stabilizer Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Transthyretin Stabilizer Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Transthyretin Stabilizer Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Transthyretin Stabilizer Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Transthyretin Stabilizer Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Transthyretin Stabilizer Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Transthyretin Stabilizer Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Transthyretin Stabilizer Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Transthyretin Stabilizer Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Transthyretin Stabilizer Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Transthyretin Stabilizer Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Transthyretin Stabilizer Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Transthyretin Stabilizer Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Transthyretin Stabilizer Sales Value by Region (2019-2024) & (%)

Table 44. Global Transthyretin Stabilizer Sales Value by Region (2025-2030) & (%)

Table 45. Global Transthyretin Stabilizer Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Transthyretin Stabilizer Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Transthyretin Stabilizer Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Transthyretin Stabilizer Sales Volume by Region (2019-2024) & (%)

Table 49. Global Transthyretin Stabilizer Sales Volume by Region (2025-2030) & (%)

Table 50. Global Transthyretin Stabilizer Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Transthyretin Stabilizer Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Transthyretin Stabilizer Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Transthyretin Stabilizer Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Transthyretin Stabilizer Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Transthyretin Stabilizer Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Transthyretin Stabilizer Sales Volume, (2025-2030) & (K Units)

Table 57. Pfizer Inc. Company Information

Table 58. Pfizer Inc. Introduction and Business Overview

Table 59. Pfizer Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Pfizer Inc. Transthyretin Stabilizer Product Offerings

Table 61. Pfizer Inc. Recent Development

Table 62. Merck & Co. Company Information

Table 63. Merck & Co. Introduction and Business Overview

Table 64. Merck & Co. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Merck & Co. Transthyretin Stabilizer Product Offerings

Table 66. Merck & Co. Recent Development

Table 67. AstraZeneca Plc. Company Information

Table 68. AstraZeneca Plc. Introduction and Business Overview

Table 69. AstraZeneca Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. AstraZeneca Plc. Transthyretin Stabilizer Product Offerings

Table 71. AstraZeneca Plc. Recent Development

Table 72. GlaxoSmithKline Plc. Company Information

Table 73. GlaxoSmithKline Plc. Introduction and Business Overview

Table 74. GlaxoSmithKline Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. GlaxoSmithKline Plc. Transthyretin Stabilizer Product Offerings

Table 76. GlaxoSmithKline Plc. Recent Development

Table 77. Corino Therapeutics Inc. Company Information

Table 78. Corino Therapeutics Inc. Introduction and Business Overview

Table 79. Corino Therapeutics Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Corino Therapeutics Inc. Transthyretin Stabilizer Product Offerings

Table 81. Corino Therapeutics Inc. Recent Development

Table 82. Alnylam Pharmaceuticals Company Information

Table 83. Alnylam Pharmaceuticals Introduction and Business Overview

Table 84. Alnylam Pharmaceuticals Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Alnylam Pharmaceuticals Transthyretin Stabilizer Product Offerings

Table 86. Alnylam Pharmaceuticals Recent Development

Table 87. Bellus Health Inc. Company Information

Table 88. Bellus Health Inc. Introduction and Business Overview

Table 89. Bellus Health Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Bellus Health Inc. Transthyretin Stabilizer Product Offerings

Table 91. Bellus Health Inc. Recent Development

Table 92. Ionis Pharmaceuticals, Inc. Company Information

Table 93. Ionis Pharmaceuticals, Inc. Introduction and Business Overview

Table 94. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Offerings

Table 96. Ionis Pharmaceuticals, Inc. Recent Development

Table 97. Proclara Bioscience Company Information

Table 98. Proclara Bioscience Introduction and Business Overview

Table 99. Proclara Bioscience Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Proclara Bioscience Transthyretin Stabilizer Product Offerings

Table 101. Proclara Bioscience Recent Development

Table 102. Arturus Therapeutics Company Information

Table 103. Arturus Therapeutics Introduction and Business Overview

Table 104. Arturus Therapeutics Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Arturus Therapeutics Transthyretin Stabilizer Product Offerings

Table 106. Arturus Therapeutics Recent Development

Table 107. Prothena Corporation Plc. Company Information

Table 108. Prothena Corporation Plc. Introduction and Business Overview

Table 109. Prothena Corporation Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Prothena Corporation Plc. Transthyretin Stabilizer Product Offerings

Table 111. Prothena Corporation Plc. Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Transthyretin Stabilizer Downstream Customers

Table 115. Transthyretin Stabilizer Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Transthyretin Stabilizer Product Picture

Figure 2. Global Transthyretin Stabilizer Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Transthyretin Stabilizer Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Transthyretin Stabilizer Sales Volume (2019-2030) & (K Units)

Figure 5. Global Transthyretin Stabilizer Sales Price (2019-2030) & (US$/Unit)

Figure 6. Transthyretin Stabilizer Report Years Considered

Figure 7. Global Transthyretin Stabilizer Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Transthyretin Stabilizer Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Transthyretin Stabilizer Revenue in 2023

Figure 10. Transthyretin Stabilizer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Diflunisal Picture

Figure 12. Tafamidis Picture

Figure 13. Others Picture

Figure 14. Global Transthyretin Stabilizer Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Transthyretin Stabilizer Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Transthyretin Stabilizer Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Transthyretin Stabilizer Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Transthyretin Stabilizer Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Hospital Pharmacies

Figure 20. Product Picture of Retail Pharmacies

Figure 21. Product Picture of Drug Stores

Figure 22. Product Picture of Online Pharmacies

Figure 23. Product Picture of Others

Figure 24. Global Transthyretin Stabilizer Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Transthyretin Stabilizer Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Transthyretin Stabilizer Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Transthyretin Stabilizer Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Transthyretin Stabilizer Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Transthyretin Stabilizer Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Transthyretin Stabilizer Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Transthyretin Stabilizer Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Transthyretin Stabilizer Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Transthyretin Stabilizer Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Transthyretin Stabilizer Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Transthyretin Stabilizer Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Transthyretin Stabilizer Sales Volume (%), (2019-2030)

Figure 41. United States Transthyretin Stabilizer Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Transthyretin Stabilizer Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Transthyretin Stabilizer Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Transthyretin Stabilizer Sales Value by Application (%), 2023 VS 2030

Figure 47. China Transthyretin Stabilizer Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

Figure 49. China Transthyretin Stabilizer Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Transthyretin Stabilizer Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Transthyretin Stabilizer Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Transthyretin Stabilizer Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Transthyretin Stabilizer Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Transthyretin Stabilizer Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Transthyretin Stabilizer Sales Value by Application (%), 2023 VS 2030

Figure 59. India Transthyretin Stabilizer Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Transthyretin Stabilizer Sales Value by Type (%), 2023 VS 2030

Figure 61. India Transthyretin Stabilizer Sales Value by Application (%), 2023 VS 2030

Figure 62. Transthyretin Stabilizer Industrial Chain

Figure 63. Transthyretin Stabilizer Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Transthyretin Stabilizer market size from 2024 to 2030? zhanKai

The annual compound growth rate of the global Transthyretin Stabilizer market is 6.9% 2024 to 2030.

Which companies rank high in the global Transthyretin Stabilizer market? shouQi

What was the global market size of Transthyretin Stabilizer in 2030? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Transthyretin Stabilizer in 2024? shouQi

Related Reports

Global Transthyretin Stabilizer Market Research Report 2025
The global market for Transthyretin Stabilizer was valued at US$ 1590 million in the year 2024 and is projected to reach a revised size of US$ 2520 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published Date: 2025-01-01
Pages: 92
USD 2900.00
(Single User License)
Global Transthyretin Stabilizer Market Insights, Forecast to 2030
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.
Published Date: 2024-04-12
Pages: 112
USD 4900.00
(Single User License)
Global Transthyretin Stabilizer Market Research Report 2024
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)

Global Transthyretin Stabilizer Market Research Report 2025
The global market for Transthyretin Stabilizer was valued at US$ 1590 million in the year 2024 and is projected to reach a revised size of US$ 2520 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published: 2025-01-01
Pages: 92
USD 2900.00 (Single User License)
Global Transthyretin Stabilizer Market Insights, Forecast to 2030
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.
Published: 2024-04-12
Pages: 112
USD 4900.00 (Single User License)
Global Transthyretin Stabilizer Market Research Report 2024
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.
Published: 2024-01-17
Pages: 89
USD 2900.00 (Single User License)